Adamas Pharmaceuticals, Inc. Net Profit Margin 2014-2021 | ADMS
Adamas Pharmaceuticals, Inc. net profit margin from 2014 to 2021. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2021-09-30 | $0.09B | $-0.06B | -71.59% |
| 2021-06-30 | $0.08B | $-0.06B | -67.07% |
| 2021-03-31 | $0.08B | $-0.05B | -68.35% |
| 2020-12-31 | $0.07B | $-0.06B | -78.38% |
| 2020-09-30 | $0.07B | $-0.06B | -91.30% |
| 2020-06-30 | $0.06B | $-0.08B | -125.40% |
| 2020-03-31 | $0.06B | $-0.09B | -163.16% |
| 2019-12-31 | $0.06B | $-0.11B | -192.73% |
| 2019-09-30 | $0.05B | $-0.11B | -215.38% |
| 2019-06-30 | $0.05B | $-0.12B | -238.78% |
| 2019-03-31 | $0.04B | $-0.13B | -286.36% |
| 2018-12-31 | $0.04B | $-0.13B | -374.29% |
| 2018-09-30 | $0.02B | $-0.13B | -569.57% |
| 2018-06-30 | $0.01B | $-0.12B | -1008.33% |
| 2018-03-31 | $0.00B | $-0.11B | -2700.00% |
| 2017-09-30 | $0.00B | $-0.08B | inf% |
| 2017-06-30 | $0.00B | $-0.07B | inf% |
| 2016-12-31 | $0.00B | $-0.06B | inf% |
| 2016-09-30 | $0.00B | $-0.06B | -5600.00% |
| 2016-06-30 | $0.00B | $-0.06B | -2850.00% |
| 2016-03-31 | $0.00B | $-0.05B | -2700.00% |
| 2015-12-31 | $0.00B | $-0.05B | -2600.00% |
| 2015-09-30 | $0.03B | $-0.03B | -106.45% |
| 2015-06-30 | $0.03B | $-0.03B | -93.33% |
| 2015-03-31 | $0.06B | $0.00B | 3.64% |
| 2014-12-31 | $0.06B | $0.01B | 14.55% |
| 2014-09-30 | $0.07B | $0.02B | 33.85% |
| 2014-06-30 | $0.07B | $0.03B | 44.62% |
| 2014-03-31 | $0.04B | $0.01B | 25.00% |
| 2013-12-31 | $0.07B | $0.03B | 47.89% |
